Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jun 4, 2026
Reporting period
Not applicable
Filed with the SEC
Jun 8, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001022079-26-000053
Filed / recorded
Jun 8, 2026, 8:32 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
QUEST DIAGNOSTICS INC
Issuer CIK
1022079
Ticker
DGX
Reporting person
Karthik Kuppusamy
Relationship
Officer
Officer title
SVP, Clinical Solutions
Security
Non-Qualifed Stock Option (right to buy)
Table
Derivative (Table II)
Transaction date
Jun 4, 2026
Transaction code
M
Shares / units
3,320
Price per share
$127.725
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
The options vested in three annual installments beginning with the first on February 24, 2023, the second on February 24, 2024 and the final on February 24, 2025.